Showing results (101-110 of 184) with videos related to
Sort By:
Pageof 19
Breast Cancer Research and Treatment|April 1, 1997
Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patientsJ Grøndahl-Hansen, S G Hilsenbeck, I J Christensen, et al.Cancer|April 7, 1998
bcl-2 and apoptosis in lymph node positive breast carcinomaM D Berardo, R M Elledge, C de Moor, et al.Oncology Nursing Forum|October 1, 1993
Pitfalls in quality-of-life assessment: lessons from a Southwest Oncology Group breast cancer clinical trialK A Hayden, C M Moinpour, B Metch, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancerS M Townson, T Sullivan, Q Zhang, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group StudyC K Osborne, B A Blumenstein, E D Crawford, et al.Breast Cancer Research and Treatment|January 1, 1986
The use of restriction fragment polymorphisms to identify the cell line MCF-7K A Graham, J M Trent, C K Osborne, et al.Cancer Research|January 1, 1983
Multiple estrogen receptor assays in human breast cancerD F Hull, G M Clark, C K Osborne, et al.Breast Cancer Research and Treatment|January 1, 1993
Measurement of steroid hormone receptors in breast cancer patients on tamoxifenC A Encarnación, D R Ciocca, W L McGuire, et al.Investigational New Drugs|January 1, 1983
Anaphylactoid reactions associated with bisantrene infusionsJ W Myers, D D Von Hoff, J G Kuhn, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant therapy of breast cancer: Southwest Oncology Group studiesC K Osborne, S E Rivkin, R W McDivitt, et al.Pageof 19